Previously, after analysis of the significance of the content ratios for different subpopulations of EC cells when maintaining tumor growth, we proposed to use the CD44high/CD117+ ratio as a prognostic criterion of tumor development [22]. This evidence concerns the gene KIT and neoplasm.